GRAL GRAIL Inc.

Subscribe to $GRAL

GRAIL Inc.

Subscribe to $GRAL

$GRAL

Medical Specialities

Health Care

IPO Year:

Exchange: NASDAQ

Recent Analyst Ratings for GRAIL Inc.

Date	Price Target	Rating	Analyst
4/21/2025	$32.00	Buy	Canaccord Genuity
11/27/2024	$16.00	Equal-Weight	Morgan Stanley
11/15/2024		Peer Perform	Wolfe Research
10/17/2024		Neutral	Guggenheim

See more ratings

GRAIL Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President Ofman Joshua J. sold $410,019 worth of shares (9,692 units at $42.30), decreasing direct ownership by 2% to 501,768 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
6/16/25 4:08:27 PM ET
$GRAL
Medical Specialities
Health Care
Director Summe Gregory L was granted 6,082 shares, increasing direct ownership by 19% to 37,544 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
5/30/25 7:24:34 PM ET
$GRAL
Medical Specialities
Health Care
Director Chase William J was granted 6,082 shares, increasing direct ownership by 20% to 35,782 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
5/30/25 7:23:43 PM ET
$GRAL
Medical Specialities
Health Care
Director Mizell Steven was granted 6,082 shares, increasing direct ownership by 21% to 35,685 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
5/30/25 7:22:57 PM ET
$GRAL
Medical Specialities
Health Care
Director Krevans Sarah was granted 6,082 shares, increasing direct ownership by 20% to 37,137 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
5/30/25 7:21:56 PM ET
$GRAL
Medical Specialities
Health Care
President Ofman Joshua J. sold $1,635,867 worth of shares (48,213 units at $33.93), decreasing direct ownership by 9% to 511,460 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
5/5/25 9:44:24 PM ET
$GRAL
Medical Specialities
Health Care
Chief Financial Officer Freidin Aaron sold $1,396,220 worth of shares (41,150 units at $33.93), decreasing direct ownership by 12% to 294,020 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
5/5/25 8:46:25 PM ET
$GRAL
Medical Specialities
Health Care
Chief Executive Officer Ragusa Robert P sold $3,190,608 worth of shares (94,035 units at $33.93), decreasing direct ownership by 11% to 734,627 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
5/5/25 8:44:41 PM ET
$GRAL
Medical Specialities
Health Care
Director Chase William J was granted 784 shares, increasing direct ownership by 3% to 29,700 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
4/16/25 6:34:35 PM ET
$GRAL
Medical Specialities
Health Care
Director Mizell Steven was granted 760 shares, increasing direct ownership by 3% to 29,603 units (SEC Form 4)
4 - GRAIL, Inc. (0001699031) (Issuer)
4/16/25 6:32:53 PM ET
$GRAL
Medical Specialities
Health Care

GRAIL Inc.

Recent Analyst Ratings for GRAIL Inc.

GRAIL Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President Ofman Joshua J. sold $410,019 worth of shares (9,692 units at $42.30), decreasing direct ownership by 2% to 501,768 units (SEC Form 4)

Director Summe Gregory L was granted 6,082 shares, increasing direct ownership by 19% to 37,544 units (SEC Form 4)

Director Chase William J was granted 6,082 shares, increasing direct ownership by 20% to 35,782 units (SEC Form 4)

Director Mizell Steven was granted 6,082 shares, increasing direct ownership by 21% to 35,685 units (SEC Form 4)

Director Krevans Sarah was granted 6,082 shares, increasing direct ownership by 20% to 37,137 units (SEC Form 4)

President Ofman Joshua J. sold $1,635,867 worth of shares (48,213 units at $33.93), decreasing direct ownership by 9% to 511,460 units (SEC Form 4)

Chief Financial Officer Freidin Aaron sold $1,396,220 worth of shares (41,150 units at $33.93), decreasing direct ownership by 12% to 294,020 units (SEC Form 4)

Chief Executive Officer Ragusa Robert P sold $3,190,608 worth of shares (94,035 units at $33.93), decreasing direct ownership by 11% to 734,627 units (SEC Form 4)

Director Chase William J was granted 784 shares, increasing direct ownership by 3% to 29,700 units (SEC Form 4)

Director Mizell Steven was granted 760 shares, increasing direct ownership by 3% to 29,603 units (SEC Form 4)